Observational studyJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2026
Impact of frailty on outcomes after ventricular tachycardia ablation: A prospective observational study.
Observational study in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAblation is an important treatment modality for ventricular tachycardia (VT). With the growing older population, frailty is a rising concern for ablation procedures. This study investigated the prognostic significance of frailty parameters in patients undergoing VT ablation.
methodsThe patients with ventricular arrhythmias due to ischemic cardiomyopathy, non-ischemic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, and R-on-T phenomenon were included. Frailty was assessed using the Clinical Frailty Scale (CFS), Timed Up and Go (TUG), four-meter walking speed, and Tilburg Frailty Indicator (TFI). A 12-month follow-up was performed for survival and VT recurrence.
resultsA total of 50 patients were prospectively included in the study. The mean age was 58.3 ± 13.8 years, and 90% were male. 26 patients (52%) died or were hospitalized for VT recurrence during 12-month follow-up. Worse outcomes were associated with a slower four-meter walking speed (p = 0.043), longer TUG (p = 0.042), and higher CFS (p = 0.047). No significant difference was found in TFI values. On Cox analysis, frailty was associated with post-VT ablation mortality (CFS hazard ratio [HR] = 1.676, 95% confidence interval [CI] = 1.141–2.464; p = 0.009, TUG HR = 1.041, 95% CI = 1.018–1.065; p = 0.001, four-meter gait speed HR = 0.17, 95% CI = 0.041–0.708; p = 0.015). ROC analysis revealed that the AUC was 0.732 for the TUG test and 0.739 for the 4-m walk test. Kaplan–Meier survival analysis demonstrated that increasing frailty was associated with higher all-cause mortality.
conclusionFrailty was found to be associated with increased mortality and recurrence following VT ablation. Future prospective studies with large patient cohort should validate these findings and explore role of frailty in this population.
Indexed as
Identifiers
40993308What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.